Skip to main content
Top
Published in: International Orthopaedics 6/2016

01-06-2016 | Original Paper

Surgical debridement with retention of spinal instrumentation and long-term antimicrobial therapy for multidrug-resistant surgical site infections after spinal surgery: a case series

Authors: Shingo Miyazaki, Kenichiro Kakutani, Koichiro Maeno, Toru Takada, Takashi Yurube, Masahiro Kurosaka, Kotaro Nishida

Published in: International Orthopaedics | Issue 6/2016

Login to get access

Abstract

Purpose

Post-operative surgical site infection (SSI) is one of the most significant complications after instrumented spinal surgery. However, implant retention feasibility for early-onset multidrug-resistant SSI is still controversial. We aimed to verify our therapeutic strategy, surgical debridement with implant retention and long-term antimicrobial therapy for post-operative early-onset multidrug-resistant SSI.

Methods

We retrospectively analyzed the clinical course of 11 cases [eight men and three women, with a mean age of 70.4 (54–82) years] with early-onset multidrug-resistant SSI out of 409 consecutive cases of spinal instrumentation surgery performed between 2007 and 2013 at our institution.

Results

The median duration of follow-up was 868 (178–1,922) days. All SSIs were controlled, without recurrence during follow-up. The microbial pathogens were methicillin-resistant Staphylococcus aureus (seven cases), multidrug-resistant Corynebacterium (two cases), methicillin-resistant Staphylococcus epidermidis (one case), and methicillin-resistant coagulase-negative Staphylococcus aureus (one case). The mean duration from SSI diagnosis to surgery was 2.9 (1–6) days. Ten patients underwent surgical debridement with implant retention. No patients required multiple operations. All patients were given antimicrobial treatments. Mean duration of intravenous antimicrobials (vancomycin, vancomycin+ piperacillin/tazobactam, or gentamicin) was 66.5 (12–352) days and 336 (89–1,673) days for oral antimicrobials (rifampicin + sulfamethoxazole/trimethoprim, sulfamethoxazole/trimethoprim, or minomycin). The mean duration of clinical signs and symptom recovery was 31.0 (7–73) days, and the mean time for normalization of C-reactive protein was 54.5 (7–105) days.

Conclusions

Early-onset multidrug-resistant SSI was successfully treated by surgical debridement with implant retention and long-term antimicrobial therapy.
Literature
2.
3.
go back to reference Weinstein MA, McCabe JP, Cammisa FP Jr (2000) Postoperative spinal wound infection: a review of 2,391 consecutive index procedures. J Spinal Disord 13:422–426CrossRefPubMed Weinstein MA, McCabe JP, Cammisa FP Jr (2000) Postoperative spinal wound infection: a review of 2,391 consecutive index procedures. J Spinal Disord 13:422–426CrossRefPubMed
5.
go back to reference Glassman SD, Dimar JR, Puno RM, Johnson JR (1996) Salvage of instrumental lumbar fusions complicated by surgical wound infection. Spine 21:2163–2169CrossRefPubMed Glassman SD, Dimar JR, Puno RM, Johnson JR (1996) Salvage of instrumental lumbar fusions complicated by surgical wound infection. Spine 21:2163–2169CrossRefPubMed
7.
go back to reference Kowalski TJ, Berbari EF, Huddleston PM, Steckelberg JM, Mandrekar JN, Osmon DR (2007) The management and outcome of spinal implant infections: contemporary retrospective cohort study. Clin Infect Dis 44:913–920. doi:10.1086/512194 CrossRefPubMed Kowalski TJ, Berbari EF, Huddleston PM, Steckelberg JM, Mandrekar JN, Osmon DR (2007) The management and outcome of spinal implant infections: contemporary retrospective cohort study. Clin Infect Dis 44:913–920. doi:10.​1086/​512194 CrossRefPubMed
8.
go back to reference Viola RW, King HA, Adler SM, Wilson CB (1997) Delayed infection after elective spinal instrumentation and fusion. A retrospective analysis of eight cases. Spine 22:2444–2450, discussion 2450–2441 CrossRefPubMed Viola RW, King HA, Adler SM, Wilson CB (1997) Delayed infection after elective spinal instrumentation and fusion. A retrospective analysis of eight cases. Spine 22:2444–2450, discussion 2450–2441 CrossRefPubMed
14.
16.
go back to reference Ammerlaan HS, Kluytmans JA, Wertheim HF, Nouwen JL, Bonten MJ (2009) Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 48:922–930. doi:10.1086/597291 CrossRefPubMed Ammerlaan HS, Kluytmans JA, Wertheim HF, Nouwen JL, Bonten MJ (2009) Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 48:922–930. doi:10.​1086/​597291 CrossRefPubMed
17.
go back to reference Falagas ME, Bliziotis IA, Fragoulis KN (2007) Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials. Am J Infect Control 35:106–114. doi:10.1016/j.ajic.2006.09.005 CrossRefPubMed Falagas ME, Bliziotis IA, Fragoulis KN (2007) Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials. Am J Infect Control 35:106–114. doi:10.​1016/​j.​ajic.​2006.​09.​005 CrossRefPubMed
19.
go back to reference Walsh TJ, Standiford HC, Reboli AC, John JF, Mulligan ME, Ribner BS, Montgomerie JZ, Goetz MB, Mayhall CG, Rimland D et al (1993) Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome. Antimicrob Agents Chemother 37:1334–1342CrossRefPubMedPubMedCentral Walsh TJ, Standiford HC, Reboli AC, John JF, Mulligan ME, Ribner BS, Montgomerie JZ, Goetz MB, Mayhall CG, Rimland D et al (1993) Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome. Antimicrob Agents Chemother 37:1334–1342CrossRefPubMedPubMedCentral
21.
go back to reference Stein A, Bataille JF, Drancourt M, Curvale G, Argenson JN, Groulier P, Raoult D (1998) Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother 42:3086–3091PubMedPubMedCentral Stein A, Bataille JF, Drancourt M, Curvale G, Argenson JN, Groulier P, Raoult D (1998) Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother 42:3086–3091PubMedPubMedCentral
22.
go back to reference Elwell LP, Wilson HR, Knick VB, Keith BR (1986) In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 29:1092–1094CrossRefPubMedPubMedCentral Elwell LP, Wilson HR, Knick VB, Keith BR (1986) In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 29:1092–1094CrossRefPubMedPubMedCentral
23.
go back to reference Nemoto T, Yamasaki Y, Torikai K, Ishii O, Fujitani S, Matsuda T (2012) A case of MRSA infection in multiple artificial joints successfully treated with conservative medical treatment. Kansenshogaku Zasshi 86:411–414CrossRefPubMed Nemoto T, Yamasaki Y, Torikai K, Ishii O, Fujitani S, Matsuda T (2012) A case of MRSA infection in multiple artificial joints successfully treated with conservative medical treatment. Kansenshogaku Zasshi 86:411–414CrossRefPubMed
24.
go back to reference Fujino T, Amari Y, Mohri M, Noma M, Yamamoto H (2009) MRSA tricuspid valve infective endocarditis with multiple embolic lung abscesses treated by combination therapy of vancomycin, rifampicin, and sulfamethoxazole/trimethoprim. J Cardiol 53:146–149. doi:10.1016/j.jjcc.2008.06.007 CrossRefPubMed Fujino T, Amari Y, Mohri M, Noma M, Yamamoto H (2009) MRSA tricuspid valve infective endocarditis with multiple embolic lung abscesses treated by combination therapy of vancomycin, rifampicin, and sulfamethoxazole/trimethoprim. J Cardiol 53:146–149. doi:10.​1016/​j.​jjcc.​2008.​06.​007 CrossRefPubMed
Metadata
Title
Surgical debridement with retention of spinal instrumentation and long-term antimicrobial therapy for multidrug-resistant surgical site infections after spinal surgery: a case series
Authors
Shingo Miyazaki
Kenichiro Kakutani
Koichiro Maeno
Toru Takada
Takashi Yurube
Masahiro Kurosaka
Kotaro Nishida
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
International Orthopaedics / Issue 6/2016
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-015-3073-3

Other articles of this Issue 6/2016

International Orthopaedics 6/2016 Go to the issue